Kip Connor, PhD, with funding from Macular Degeneration Research (MDR), has lead a team of experts to discover an important role of immune cells that regulate, and could potentially stop, abnormal blood vessel growth in advanced age-related macular degeneration (AMD).

Macular Degeneration Research grantees are looking at new ways to stop age-related macular degeneration. Two, in particular, are hoping that vitamins and diet will provide solutions.

By lending insight into early drusen formation, results of a BrightFocus MDR grant may help us treat AMD earlier and lessen our dependency on injections in its later stages to preserve sight.

Vision health needs to be more at the forefront of both public policy and public health concerns.

Learn about an exciting citizen science project receiving support from the BrightFocus Alzheimer’s Disease Research program; the first crowd-sourced effort to gather data to help end Alzheimer’s disease.

Francis Hanes, PhD, is using his knowledge of biophysics to advance Alzheimer’s imaging and achieve earlier diagnosis. Read about his BrightFocus-funded research.

Top U.S. scientists are concerned that eye and vision health are relatively absent from national health priority lists. AMD, in particular, is rising..

Currently there is no treatment available for advanced dry AMD that can cause vision loss, also known as geographic atrophy. However, BrightFocus-funded researchers are working on the early stages of a possible solution.